Malin

HealthBeacon raises €6m in investment from Elkstone and Crow Rock

Dublin-headquartered company helps patients better adhere to medication schedules

Malin to receive €68m after disposing of Altan shareholding

Life sciences company had a 65% stake in Altan, which it acquired for €34.5m in 2015

Malin completes sale of Kymab to Sanofi for $1.1bn

Life sciences investor said sale would deliver gross upfront proceeds of $113m

Malin investors cautious on investment doubling in value

Cantillon: Malin prevented from selling stock for at least 180 days under lock-up agreement

Malin-backed Immunocore files for $258m Nasdaq IPO

The UK biotech company says proceeds from the IPO will be used to advance its lead product

Malin-backed Immunocore files for $100m IPO

Irish investor has 7.4% stake in UK biotech company developing eye cancer therapy

Time for Malin to decide what it wants to be when it grows up

Market Beat: Life sciences company is finally delivering, six years after IPO

Malin to make up to $145m from sale of Kymab to Sanofi

Irish life sciences company holds 10% stake in immunotherapy firm

Malin Corp looks to benefit from Covid and promises returns

Life sciences investment firm has said its revenue-generating assets performing well

Complete Budget 2021 coverage, €250m for Malin shareholders, and the latest from the FBD and INM court cases

Business Today: the best news, analysis and comment from The Irish Times business desk

Malin-backed company announces initial IPO price

Poseida Therapeutics is expected to begin trading on the Nasdaq on Friday

Malin shares still trading well below real value, CEO says

Shares in Dublin-based life sciences group have rallied by more than 250% since March

Malin-backed Poseida Therapeutics files for IPO on Nasdaq exchange

Poseida is one of four priority assets in which the life sciences company has stakes

Malin sees clinical trials delays amid Covid-19 crisis

Germ-zapping robot firm backed by Malin sees spike in demand amid virus outbreak

‘Serious gender imbalance’ remains at top of Irish business, report finds

New targets set for inclusion of women on leadership teams and in private companies

Irish healthcare app founders get €28m from 3D4Medical sale

Healthcare investor Malin receives €17m for its stake following sale of business to Elsevier

Irish shares rally on hopes Farage has boosted Johnson’s Brexit deal

Markets report: Investors grappled with issues ranging from violent Hong Kong protests to Spanish election results

Former Elan executive Given joins Philip Lee’s corporate deals team

Top lawyer John Given joined Elan in 2013 just as the drugmaker was subject of takeover battle

As Oracle of Oxford calls it a day Malin set to feel Woodford effect

WEIF remains co-investor in three of Malin’s four main investee companies

Malin dismisses Woodford fund wind-up impact on key investments

Woodford Equity Income Fund enters liquidation over issues revealed in June

Banks lead rally on growing prospect of Brexit deal

Markets: Positive Brexit sentiment drives share values in Dublin and London

US hedge fund snaps up Woodfords’ Malin stake

Pentwater bought shares at 60% discount to Malin’s ‘intrinsic value’

Woodford sells remaining Malin stake

Troubled asset manager thought to have sold 1.6m shares earlier this week

Woodford effect lingers at Malin despite shares sell-off

Once-revered UK stock picker still linked to Irish life-sciences investment company

Malin’s troubled main shareholder Woodford sells most of stake

UK asset manager offloads 9.1 million shares in Irish life sciences investment company

Malin chief sees demand for 23% Woodford stake

New CEO says company will have enough investor demand to absorb the holding if sold

Malin names Darragh Lyons CEO as investments value drops

Value of portfolio fell 5% in first half of the year

Irish listed companies set to miss target for gender diversity on boards

Business equality group says 15 listed companies still have ‘zero female directors’

European shares drop on weak Chinese data and trade fears

Iseq drops 1.5% as CRH pulls back in line with a broad sell-off by European and US peers

Malin and Hostelworld drop as fund shuts gates on cash-ins

Legendary fund manager Neil Woodford blocks investors withdrawing their money

Malin-backed eczema drug company signals IPO

Biopharmaceutical company Kymab identified as one of Malin’s four ‘core assets’

Malin chairman Ian Curley signals departure plans

Business veteran has overseen review of investment group’s portfolio

Malin-backed biotech company raises $142m

Poseida Therapeutics uses genome engineering to develop cancer treatments

Dublin-listed Malin had assets worth €404m at end of last year

Life sciences investor says it is focused on supporting assets amid board upheaval

Malin investee company Poseida Therapeutics files for potential US IPO

US clinical-stage biotechnology company is eyeing a listing on the Nasdaq Global Select Market

Nuritas secures €30m investment from EU’s financial arm

Biotech firm uses data mining of molecules in food to identify supplements and new drugs

European and Apple shares continue to drop amid Brexit and production fears

Iseq index in Dublin falls by 1.4 per cent to fresh two-year low

Malin pledges to return cash to shareholders

Four main assets on track to reach ‘important milestones’

Stock markets rise globally as investors cheer gridlocked US Congress

US midterm results eased fears that Trump’s deregulation measures would be reversed

Brexit tug-of-war gathers steam with six months to go

Business Week: also in the news was Ryanair woes; corporates; and economic indicators

YOU MAY ALSO LIKE...
The Irish Times ePaper

France 2003

Rugby World Cup: match analysis, interviews, fixtures and results

Stardust

Inquests into the nightclub fire that led to the deaths of 48 people